Watch again as an expert panel shares key insights on the current front-line treatment landscape for CLL and the selection of optimal therapy for improved patient outcomes while discussing the implications for practice in Australia.

Hosted by Associate Professor Mary Ann Anderson.
Consultant Haematologist, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital; Clinician Scientist, Blood Cells and Blood Cancer, the Walter and Eliza Hall Institute of Medical Research.

PANEL 

Dr Kyle Crassini. Clinical Haematologist, Coffs Harbour Health Campus, NSW

Dr Monique Menzies Wojtowicz. Haematologist, Macquarie University Hospital and Northern Beaches Hospital.

For more information please contact [email protected]

Thank you to our sponsor

This event was supported by an unrestricted educational grant and created independently by the limbic in collaboration with the host and panel. All studies are selected by the panel and all views expressed are those of the host and panel only.